MBS621619 | BACE, Asp2 (CT) (Memapsin2, Beta-site APP Cleaving Enzyme, Aspartyl Protease 2)

BACE, Asp2 (CT) (Memapsin2, Beta-site APP Cleaving Enzyme, Aspartyl Protease 2) | MBS621619 | MyBiosource

Product Short Name: [BACE, Asp2]

Product Name Synonyme: [Anti -BACE, Asp2 (CT) (Memapsin2, Beta-site APP Cleaving Enzyme, Aspartyl Protease 2)]

Other Names: [beta-secretase 1 isoform D preproprotein; Beta-secretase 1; beta-secretase 1; asp 2; memapsin-2; APP beta-secretase; aspartyl protease 2; beta-site APP cleaving enzyme 1; beta-secretase 1 precursor variant 1; transmembrane aspartic proteinase Asp2; membrane-associated aspartic protease 2; beta-site amyloid beta A4 precursor protein-cleaving enzyme; beta-site APP-cleaving enzyme 1; Aspartyl protease 2; ASP2; Asp 2; Beta-site amyloid precursor protein cleaving enzyme 1; Beta-site APP cleaving enzyme 1; Memapsin-2; Membrane-associated aspartic protease 2]

Product Gene Name: N/A

Product Gene Name Synonyme: N/A

Other Gene Names: [BACE1; BACE1; ASP2; BACE; HSPC104; BACE; KIAA1149; ASP2; Asp 2]

Clonality: Polyclonal

Isotype: IgG

Clone: N/A

Host: Goat

Reactivity: Human

Specificity: Recognizes human beta amyloid cleaving enzyme (BACE), a 70kD aspartic protease. BACE is involved in the cleavage of the amyloid precursor protein (APP) to generate amyloid beta peptide. Cerebral deposition of amyloid beta peptide is an early feature of Alzheimer's disease.

Purity: Serum
Serum.

Form: Serum. Supplied as a liquid with 0.1% sodium azide.

Concentration: N/A

Storage Stability: -20 degree C

Tested Application: Immunohistochemistry (IHC)